📣 VC round data is live. Check it out!
- Public Comps
- Oxiquim
Oxiquim Valuation Multiples
Discover revenue and EBITDA valuation multiples for Oxiquim and similar public comparables like NL Industries, Messer Tehnogas, Natac Natural Ingredients, Valhi and more.
Oxiquim Overview
About Oxiquim
Oxiquim SA focuses on the marketing of chemical products and the provision of services related to the chemical sector. It is engaged in the production, transformation, sale, export, and distribution of all types of chemical, petrochemical, pharmaceutical, cosmetic, and general chemical products. The company's other business activities include the provision of engineering and maintenance services, the operation and exploitation of maritime terminals, and the production and sale of resins and adhesive mixtures. The company's operating segments are; Commercial which derives maximum revenue, and Services.
Founded
1980
HQ

Employees
428
Website
Sectors
Financials (FY)
EV
$398M
Valuation Multiples
Start free trialOxiquim Financials
Oxiquim reported last fiscal year revenue of $263M and EBITDA of $42M.
In the same fiscal year, Oxiquim generated $92M in gross profit, $42M in EBITDA, and $29M in net income.
Oxiquim P&L
In the most recent fiscal year, Oxiquim reported revenue of $263M and EBITDA of $42M.
Oxiquim is profitable as of last fiscal year, with gross margin of 35%, EBITDA margin of 16%, and net margin of 11%.
Financial data powered by Morningstar, Inc.
Oxiquim Stock Performance
Oxiquim has current market cap of $344M, and enterprise value of $398M.
Market Cap Evolution
Oxiquim's stock price is $13.82.
Oxiquim share price increased by 0.3% in the last 30 days, and by 25.3% in the last year.
Oxiquim has an EPS (earnings per share) of $1.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $398M | $344M | -0.3% | 0.3% | 0.2% | 25.3% | $1.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOxiquim Valuation Multiples
Oxiquim trades at 1.5x EV/Revenue multiple, and 9.5x EV/EBITDA.
Oxiquim Financial Valuation Multiples
As of May 20, 2026, Oxiquim has market cap of $344M and EV of $398M.
Oxiquim has a P/E ratio of 11.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Oxiquim Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Oxiquim Margins & Growth Rates
In the most recent fiscal year, Oxiquim reported gross margin of 35%, EBITDA margin of 16%, and net margin of 11%.
Oxiquim Margins
Oxiquim Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Oxiquim Operational KPIs
Oxiquim's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Oxiquim Competitors
Oxiquim competitors include NL Industries, Messer Tehnogas, Natac Natural Ingredients, Valhi, Ercros, Alto Ingredients, Orion SA, Samyang Holdings, Itafos and Sniezka.
Most Oxiquim public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.6x | 1.6x | (5.3x) | — | |||
| 1.1x | — | 3.0x | — | |||
| 7.5x | 6.5x | 25.4x | 20.3x | |||
| 0.4x | 0.4x | 10.1x | — | |||
| 0.7x | 0.7x | 64.4x | 43.4x | |||
| 0.5x | 0.5x | 9.0x | 8.3x | |||
| 0.7x | 0.7x | 5.4x | 5.9x | |||
| 0.3x | — | 3.1x | — | |||
This data is available for Pro users. Sign up to see all Oxiquim competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Oxiquim
| When was Oxiquim founded? | Oxiquim was founded in 1980. |
| Where is Oxiquim headquartered? | Oxiquim is headquartered in Chile. |
| How many employees does Oxiquim have? | As of today, Oxiquim has over 428 employees. |
| Is Oxiquim publicly listed? | Yes, Oxiquim is a public company listed on Bolsa de Santiago. |
| What is the stock symbol of Oxiquim? | Oxiquim trades under OXIQUIM ticker. |
| When did Oxiquim go public? | Oxiquim went public in 2015. |
| Who are competitors of Oxiquim? | Oxiquim main competitors include NL Industries, Messer Tehnogas, Natac Natural Ingredients, Valhi, Ercros, Alto Ingredients, Orion SA, Samyang Holdings, Itafos, Sniezka. |
| What is the current market cap of Oxiquim? | Oxiquim's current market cap is $344M. |
| What is the current revenue of Oxiquim? | Oxiquim's last fiscal year revenue is $263M. |
| What is the current EV/Revenue multiple of Oxiquim? | Current revenue multiple of Oxiquim is 1.5x. |
| Is Oxiquim profitable? | No, Oxiquim is not profitable. |
| How many companies Oxiquim has acquired to date? | Oxiquim hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Oxiquim has invested to date? | Oxiquim hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Oxiquim
Lists including Oxiquim
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.